Skip to content

Ambulant versus unattended & attended office versus self-home blood pressure measurement 2

Ambulant versus unattended & attended office versus self-home blood pressure measurement 2 - AMUSE-BP-2

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57340
Enrollment
150
Registered
2024-06-03
Start date
2025-08-14
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension High blood pressure

Interventions

Cuffless blood pressure monitoring Hilo bracelet

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Age of 18 years or older 2. Documented medical history of hypertension in local hospital electronic patient record 3. Stable dose of anti-hypertensive medication for at least 2 months (includes no current antihypertensive medication, diagnosis hypertension is sufficient) 4. SBP>90 and 60 and

Exclusion criteria

Exclusion criteria: 1. SBP >180 mmHg and/or DBP >110mmHg at inclusion screening visit (measured by  attended OBP method). 2. Any BP that according to the treating physician is not adequately controlled  and needs medication adjustment < 2 months or within the study time period. 3. Recent (<2 months) anti-hypertensive medication changes (including  diuretics). 4. Recent start or change in dosing of alpha-blockers prescribed for other  purpose than blood pressure control (for example benign prostate hypertrophy). 5. Unstable or uncontrolled endocrine disease (e.g. thyroid disease, Cushing*s  or Addison*s disease) with the exception of diabetes mellitus. 6. Arrhythmias that prevent any BP measurement device to correctly measure BP  during inclusion screening visit; such as supraventricular arrhythmias or  atrial ventricular block. Known arrhythmias, but not clinically present during  inclusion screening is not an exclusion criterion. 7. Heart failure grade 2 or higher on the New York Heart Association (NYHA)  Functional Classification. 8. Documented missed outpatient clinic appointments (2 or more the last 6  months). 9. Documented therapy non-adherence (e.g. biochemical proven medication  non-adherence, known or highly suspected medication non-adherence by treating  physician, proven direct observed therapy effect in BP). 10. Participants cannot plan a measurement schedule with a minimum of 22 and a  maximum of 31-day period participation or a minimum of 4 and maximum of 5  hospital visits due to logistical issues or scheduling issues of any kind. 11. Physical inability to perform an home BP measurement. 12. Active pregnancy or planning trying to get pregnant during the study  period.

Design outcomes

Primary

MeasureTime frame
The main study endpoint are twofold: 1. Mean differences in systolic blood pressure (SBP) and diastolic blood pressure (DBP) between cuffless BP monitoring and ABPM values. 2. Standard deviations of the mean differences between cuffless BP monitoring, ABPM, oscillometric HBPM, a-OBP and u-OBP

Secondary

MeasureTime frame
For all of the secondary objectives formulated in chapter 2 the study parameters are the same as the main study parameters. Other study variables that will be recorded for each study participant: Age, gender, arm circumference, medical history, BMI, medication use, and smoking behavior.

Countries

Netherlands

Contacts

Public ContactW. Spiering

Universitair Medisch Centrum Utrecht

w.spiering@umcutrecht.nl0031639114996

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jun 21, 2026